Skip to main content

Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials.

Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units). Current Vascular Pharmacology will publish reviews to update all those concerned with the treatment of vascular disease. For example, reviews commenting on recently published trials or new drugs will be included. In addition to clinically relevant topics we will consider 'research-based' reviews dealing with future developments and potential drug targets. Therefore, another function of Current Vascular Pharmacology is to bridge the gap between clinical practice and ongoing research.

Debates will also be encouraged in the correspondence section of this journal.

Publisher: Bentham Science Publishers

Volume 10, Number 3, May 2012

Articles

Insulin- and Growth Factor-Resistance Impairs Vascular Regeneration in Diabetes Mellitus
pp. 271-284(14)
Authors: M. Cubbon, Richard; Ali, Noman; Sengupta, Anshu; T. Kearney, Mark

Favourites:
ADD

Cell-Based Therapy to Promote Angiogenesis in the Brain Following Ischemic Damage
pp. 285-288(4)
Authors: Uemura, Masahiro; Kasahara, Yukiko; Nagatsuka, Kazuyuki; Taguchi, Akihiko

Favourites:
ADD
Favourites:
ADD

Regenerative Therapies for Improving Myocardial Perfusion in Patients with Cardiovascular Disease: Failure to Meet Expectations but Optimism for the Future
pp. 300-309(10)
Authors: W. Sellke, Frank; D. Lassaletta, Antonio; P. Robich, Michael; M. Chu, Louis; Ruel, Marc

Favourites:
ADD

Strategies for Enhancing Progenitor Cell Mobilization and Function in Diabetes
pp. 310-321(12)
Authors: Albiero, Mattia; P. Fadini, Gian

Favourites:
ADD

Clinically Relevant Extracellular-Matrix Scaffolds for Cell Transplantation and Vascular Repair
pp. 322-330(9)
Authors: Tiwari-Pandey, Rashmi; Toeg, Hadi; W. Sellke, Frank; Ruel, Marc

Favourites:
ADD

Biofunctional Materials for Directing Vascular Development
pp. 331-341(11)
Authors: E. Saik, Jennifer; K. McHale, Melissa; L. West, Jennifer

Favourites:
ADD

Using Extracellular Matrix-Derived Peptides to Alter the Microenvironment for Myocardial Repair
pp. 342-346(5)
Authors: S. Mihardja, Shirley; J. Lee, Randall

Favourites:
ADD

Tissue Engineering a Small Diameter Vessel Substitute: Engineering Constructs with Select Biomaterials and Cells
pp. 347-360(14)
Authors: E. McBane, Joanne; Sharifpoor, Soroor; S. Labow, Rosalind; Ruel, Marc; J. Suuronen, Erik; Paul Santerre, J.

Favourites:
ADD

Imaging Stem Cell Therapy for the Treatment of Peripheral Arterial Disease
pp. 361-373(13)
Authors: D. Ransohoff, Julia; C. Wu, Joseph

Favourites:
ADD

Free Content Editorial: Should Chronic Kidney Disease be Considered as a Coronary Heart Disease Equivalent?
pp. 374-377(4)
Authors: G. Athyros, Vasilios; Katsiki, Niki; Karagiannis, Asterios; P. Mikhailidis, Dimitri

Favourites:
ADD

The Effects of Newer Beta-Adrenoceptor Antagonists on Vascular Function in Cardiovascular Disease
pp. 378-390(13)
Authors: Wehland, Markus; Grosse, Jirka; Simonsen, Ulf; Infanger, Manfred; Bauer, Johann; Grimm, Daniela

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more